Study characteristics |
Methods |
Double‐blind, randomized, placebo‐controlled |
Participants |
On‐pump CABG only |
Interventions |
Propranolol vs. placebo |
Outcomes |
SVT; Mortality; CV Mortality |
Follow‐Up |
5 days |
Concurrent Antiarrhythmic Medications |
Not reported |
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Low risk |
Pharmacy‐controlled randomization and drug administration |
Allocation concealment (selection bias) |
Low risk |
Double‐blind, and pharmacy‐controlled groupings |
Blinding of participants and personnel (performance bias)
All outcomes |
Low risk |
Double‐blind |
Blinding of outcome assessment (detection bias)
All outcomes |
Low risk |
Double‐blind |
Incomplete outcome data (attrition bias)
All outcomes |
Low risk |
No missing outcome data |
Selective reporting (reporting bias) |
Low risk |
All outcomes reported |
Intention‐to‐treat analysis |
High risk |
No |